Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glaucoma | 32 | 2023 | 1159 | 5.610 |
Why?
|
Optic Disk | 15 | 2023 | 400 | 5.200 |
Why?
|
Glaucoma, Open-Angle | 20 | 2023 | 706 | 4.720 |
Why?
|
Corneal Diseases | 13 | 2023 | 636 | 3.400 |
Why?
|
Intraocular Pressure | 29 | 2023 | 1270 | 3.020 |
Why?
|
Visual Fields | 25 | 2022 | 1047 | 2.990 |
Why?
|
Tomography, Optical Coherence | 17 | 2023 | 2657 | 1.940 |
Why?
|
Optic Nerve Diseases | 5 | 2020 | 327 | 1.700 |
Why?
|
Glaucoma, Angle-Closure | 5 | 2023 | 189 | 1.610 |
Why?
|
Descemet Stripping Endothelial Keratoplasty | 2 | 2022 | 109 | 1.490 |
Why?
|
Cornea | 10 | 2023 | 1524 | 1.440 |
Why?
|
Visual Field Tests | 16 | 2023 | 383 | 1.410 |
Why?
|
Prostheses and Implants | 11 | 2023 | 1387 | 1.310 |
Why?
|
Artificial Organs | 6 | 2019 | 204 | 1.150 |
Why?
|
Visual Acuity | 13 | 2022 | 2530 | 0.940 |
Why?
|
Bruch Membrane | 3 | 2019 | 64 | 0.920 |
Why?
|
Retinal Vessels | 5 | 2020 | 772 | 0.920 |
Why?
|
Glaucoma Drainage Implants | 4 | 2019 | 116 | 0.910 |
Why?
|
Vision Disorders | 8 | 2021 | 1058 | 0.910 |
Why?
|
Retinal Ganglion Cells | 10 | 2023 | 770 | 0.850 |
Why?
|
Nerve Fibers | 8 | 2023 | 687 | 0.770 |
Why?
|
Gonioscopy | 2 | 2020 | 157 | 0.750 |
Why?
|
Filtering Surgery | 2 | 2015 | 35 | 0.650 |
Why?
|
Fluorescein Angiography | 2 | 2019 | 940 | 0.620 |
Why?
|
Fluocinolone Acetonide | 1 | 2017 | 36 | 0.610 |
Why?
|
Uveitis, Anterior | 1 | 2017 | 101 | 0.590 |
Why?
|
Tonometry, Ocular | 8 | 2022 | 237 | 0.580 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2019 | 245 | 0.580 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2019 | 357 | 0.570 |
Why?
|
Coated Materials, Biocompatible | 1 | 2017 | 319 | 0.520 |
Why?
|
Moraxellaceae Infections | 1 | 2015 | 8 | 0.520 |
Why?
|
Phacoemulsification | 3 | 2023 | 149 | 0.500 |
Why?
|
Cross-Sectional Studies | 18 | 2023 | 25043 | 0.460 |
Why?
|
Keratoplasty, Penetrating | 3 | 2022 | 155 | 0.450 |
Why?
|
Retina | 4 | 2023 | 2616 | 0.440 |
Why?
|
Eye Abnormalities | 1 | 2015 | 246 | 0.420 |
Why?
|
Endophthalmitis | 1 | 2015 | 262 | 0.410 |
Why?
|
Eye Infections, Bacterial | 1 | 2015 | 235 | 0.410 |
Why?
|
Microvessels | 3 | 2021 | 544 | 0.410 |
Why?
|
Retinoscopy | 1 | 2011 | 27 | 0.400 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2019 | 4420 | 0.390 |
Why?
|
Imaging, Three-Dimensional | 2 | 2017 | 4042 | 0.390 |
Why?
|
Retinal Detachment | 1 | 2015 | 411 | 0.380 |
Why?
|
Scotoma | 3 | 2022 | 139 | 0.370 |
Why?
|
Macula Lutea | 1 | 2011 | 151 | 0.360 |
Why?
|
Artificial Intelligence | 5 | 2020 | 2214 | 0.350 |
Why?
|
Autoimmune Diseases | 1 | 2021 | 2133 | 0.340 |
Why?
|
Ophthalmology | 1 | 2015 | 508 | 0.340 |
Why?
|
Retrospective Studies | 28 | 2023 | 77449 | 0.330 |
Why?
|
Retinal Hemorrhage | 2 | 2020 | 96 | 0.320 |
Why?
|
Capillaries | 3 | 2021 | 773 | 0.300 |
Why?
|
Thiazolidinediones | 2 | 2008 | 476 | 0.300 |
Why?
|
Nails | 2 | 2018 | 292 | 0.260 |
Why?
|
Aged | 31 | 2023 | 163280 | 0.260 |
Why?
|
PPAR gamma | 1 | 2008 | 493 | 0.260 |
Why?
|
Regional Blood Flow | 2 | 2019 | 1525 | 0.250 |
Why?
|
Humans | 63 | 2023 | 744343 | 0.250 |
Why?
|
Exfoliation Syndrome | 2 | 2017 | 110 | 0.250 |
Why?
|
Prosthesis Implantation | 5 | 2022 | 642 | 0.230 |
Why?
|
Microcirculation | 2 | 2019 | 1286 | 0.230 |
Why?
|
Ocular Hypotension | 1 | 2023 | 22 | 0.220 |
Why?
|
Education, Medical, Graduate | 1 | 2015 | 2291 | 0.220 |
Why?
|
Densitometry | 2 | 2020 | 156 | 0.220 |
Why?
|
Curriculum | 1 | 2015 | 3605 | 0.210 |
Why?
|
Prosthesis Design | 2 | 2020 | 2110 | 0.210 |
Why?
|
Middle Aged | 29 | 2023 | 213383 | 0.200 |
Why?
|
Angiogenesis Inhibitors | 3 | 2008 | 2038 | 0.190 |
Why?
|
Ocular Hypertension | 2 | 2020 | 198 | 0.190 |
Why?
|
Endothelium, Corneal | 1 | 2022 | 199 | 0.180 |
Why?
|
Burns, Chemical | 2 | 2019 | 159 | 0.180 |
Why?
|
Case-Control Studies | 5 | 2023 | 21746 | 0.180 |
Why?
|
Refractive Surgical Procedures | 1 | 2019 | 25 | 0.180 |
Why?
|
Clinical Competence | 1 | 2015 | 4687 | 0.180 |
Why?
|
Bayes Theorem | 3 | 2022 | 2309 | 0.170 |
Why?
|
Postoperative Complications | 4 | 2019 | 15295 | 0.170 |
Why?
|
Aniridia | 1 | 2019 | 37 | 0.170 |
Why?
|
Female | 31 | 2022 | 380194 | 0.170 |
Why?
|
Diabetic Retinopathy | 1 | 2008 | 1210 | 0.170 |
Why?
|
Follow-Up Studies | 8 | 2022 | 39050 | 0.170 |
Why?
|
Male | 28 | 2022 | 350118 | 0.160 |
Why?
|
Blood Sedimentation | 1 | 2019 | 231 | 0.160 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2011 | 3327 | 0.160 |
Why?
|
Artifacts | 2 | 2023 | 1904 | 0.160 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2019 | 264 | 0.150 |
Why?
|
Disease Progression | 7 | 2022 | 13284 | 0.150 |
Why?
|
Cataract Extraction | 2 | 2019 | 481 | 0.150 |
Why?
|
Retinal Artery | 1 | 2018 | 111 | 0.150 |
Why?
|
Angiography | 1 | 2022 | 1639 | 0.140 |
Why?
|
Anti-Bacterial Agents | 1 | 2015 | 7181 | 0.140 |
Why?
|
Anterior Eye Segment | 1 | 2017 | 152 | 0.140 |
Why?
|
Hypoglycemic Agents | 1 | 2008 | 2872 | 0.130 |
Why?
|
Aged, 80 and over | 12 | 2020 | 57776 | 0.130 |
Why?
|
Internship and Residency | 1 | 2015 | 5788 | 0.130 |
Why?
|
Prosthesis Failure | 1 | 2020 | 1206 | 0.120 |
Why?
|
Blister | 1 | 2015 | 86 | 0.120 |
Why?
|
Prospective Studies | 5 | 2020 | 53288 | 0.120 |
Why?
|
Algorithms | 4 | 2021 | 13881 | 0.120 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2019 | 719 | 0.110 |
Why?
|
Trabeculectomy | 1 | 2015 | 160 | 0.110 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2016 | 280 | 0.110 |
Why?
|
Monitoring, Physiologic | 1 | 2020 | 1738 | 0.100 |
Why?
|
Laser Therapy | 1 | 2019 | 1072 | 0.100 |
Why?
|
Retinal Diseases | 1 | 2018 | 683 | 0.100 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 3870 | 0.100 |
Why?
|
Leptin | 1 | 2019 | 1599 | 0.090 |
Why?
|
Blindness | 1 | 2015 | 617 | 0.090 |
Why?
|
Antihypertensive Agents | 1 | 2020 | 2046 | 0.090 |
Why?
|
Ultraviolet Rays | 1 | 2014 | 1060 | 0.090 |
Why?
|
Ciliary Body | 2 | 2021 | 173 | 0.090 |
Why?
|
Diabetes Mellitus | 1 | 2008 | 5751 | 0.090 |
Why?
|
Reproducibility of Results | 4 | 2019 | 19905 | 0.090 |
Why?
|
Regression Analysis | 2 | 2016 | 6459 | 0.080 |
Why?
|
Endoscopy | 1 | 2019 | 1785 | 0.080 |
Why?
|
Models, Statistical | 2 | 2016 | 5102 | 0.080 |
Why?
|
Educational Measurement | 1 | 2015 | 1210 | 0.080 |
Why?
|
Adult | 15 | 2020 | 214055 | 0.080 |
Why?
|
Microscopic Angioscopy | 2 | 2018 | 22 | 0.080 |
Why?
|
Caffeine | 1 | 2012 | 699 | 0.080 |
Why?
|
Coffee | 1 | 2012 | 578 | 0.080 |
Why?
|
Teaching | 1 | 2015 | 1174 | 0.080 |
Why?
|
Recovery of Function | 1 | 2017 | 2925 | 0.070 |
Why?
|
Antirheumatic Agents | 1 | 2016 | 1339 | 0.070 |
Why?
|
Thiazoles | 2 | 2003 | 1483 | 0.070 |
Why?
|
Prevalence | 1 | 2021 | 15226 | 0.060 |
Why?
|
Incidence | 1 | 2022 | 20947 | 0.060 |
Why?
|
Macular Edema | 1 | 2008 | 359 | 0.060 |
Why?
|
Treatment Outcome | 4 | 2023 | 63114 | 0.060 |
Why?
|
Central Nervous System Stimulants | 1 | 2012 | 1148 | 0.060 |
Why?
|
Longitudinal Studies | 3 | 2020 | 13989 | 0.050 |
Why?
|
Medical Records | 1 | 2008 | 1413 | 0.050 |
Why?
|
Chronic Disease | 1 | 2017 | 9146 | 0.050 |
Why?
|
Preoperative Period | 2 | 2014 | 549 | 0.050 |
Why?
|
Isoantigens | 1 | 2004 | 567 | 0.050 |
Why?
|
Risk Reduction Behavior | 1 | 2008 | 1125 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14722 | 0.050 |
Why?
|
Blood Pressure | 2 | 2018 | 8554 | 0.050 |
Why?
|
Young Adult | 5 | 2020 | 56430 | 0.050 |
Why?
|
Heart Rate | 1 | 2012 | 4091 | 0.050 |
Why?
|
Diabetes Complications | 1 | 2008 | 1359 | 0.050 |
Why?
|
Laser Coagulation | 1 | 2023 | 326 | 0.050 |
Why?
|
Aging | 1 | 2020 | 8664 | 0.050 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2003 | 419 | 0.050 |
Why?
|
Image Enhancement | 1 | 2011 | 2921 | 0.050 |
Why?
|
Environmental Exposure | 1 | 2014 | 4234 | 0.050 |
Why?
|
Risk Factors | 3 | 2022 | 72290 | 0.040 |
Why?
|
False Negative Reactions | 1 | 2020 | 588 | 0.040 |
Why?
|
Eye Burns | 1 | 2019 | 103 | 0.040 |
Why?
|
Oligopeptides | 1 | 2004 | 1189 | 0.040 |
Why?
|
Models, Biological | 1 | 2015 | 9583 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 871 | 0.040 |
Why?
|
Carbonic Anhydrase Inhibitors | 1 | 2018 | 95 | 0.040 |
Why?
|
Computer Simulation | 1 | 2011 | 6196 | 0.040 |
Why?
|
Polymethyl Methacrylate | 1 | 2017 | 145 | 0.040 |
Why?
|
Fundus Oculi | 1 | 2018 | 473 | 0.040 |
Why?
|
Retinal Vein Occlusion | 1 | 2018 | 137 | 0.040 |
Why?
|
Microscopy, Video | 1 | 2017 | 245 | 0.040 |
Why?
|
False Positive Reactions | 1 | 2019 | 981 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2004 | 2540 | 0.030 |
Why?
|
Retinal Neurons | 1 | 2015 | 66 | 0.030 |
Why?
|
Titanium | 1 | 2017 | 494 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2003 | 1071 | 0.030 |
Why?
|
Aneurysm | 1 | 2018 | 339 | 0.030 |
Why?
|
Acid-Base Equilibrium | 1 | 2014 | 185 | 0.030 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2008 | 3336 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2020 | 15076 | 0.030 |
Why?
|
Rabbits | 1 | 2019 | 4894 | 0.030 |
Why?
|
Leisure Activities | 1 | 2014 | 311 | 0.030 |
Why?
|
Sunlight | 1 | 2014 | 325 | 0.030 |
Why?
|
Occupations | 1 | 2014 | 517 | 0.030 |
Why?
|
Israel | 1 | 2014 | 796 | 0.030 |
Why?
|
Neoplasm Metastasis | 1 | 2002 | 4851 | 0.030 |
Why?
|
Neuroprotective Agents | 1 | 2018 | 941 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2016 | 2274 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2020 | 15540 | 0.020 |
Why?
|
Potassium | 1 | 2014 | 1336 | 0.020 |
Why?
|
Antineoplastic Agents | 2 | 2003 | 13695 | 0.020 |
Why?
|
ROC Curve | 1 | 2017 | 3527 | 0.020 |
Why?
|
Linear Models | 1 | 2020 | 5952 | 0.020 |
Why?
|
Postoperative Care | 1 | 2016 | 1486 | 0.020 |
Why?
|
Postoperative Period | 1 | 2014 | 1842 | 0.020 |
Why?
|
Cataract | 1 | 2014 | 834 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2018 | 1790 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8642 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2012 | 2029 | 0.020 |
Why?
|
Beverages | 1 | 2012 | 820 | 0.020 |
Why?
|
Adolescent | 3 | 2020 | 85781 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2014 | 2050 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2008 | 11725 | 0.020 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2004 | 329 | 0.010 |
Why?
|
H-2 Antigens | 1 | 2004 | 366 | 0.010 |
Why?
|
Quantum Theory | 1 | 2003 | 70 | 0.010 |
Why?
|
Cytokines | 1 | 2018 | 7322 | 0.010 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2003 | 115 | 0.010 |
Why?
|
Hydrogen | 1 | 2003 | 164 | 0.010 |
Why?
|
Transcription Factors | 1 | 2002 | 12208 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2014 | 4560 | 0.010 |
Why?
|
Molecular Conformation | 1 | 2003 | 563 | 0.010 |
Why?
|
Alanine | 1 | 2004 | 572 | 0.010 |
Why?
|
Thermodynamics | 1 | 2003 | 596 | 0.010 |
Why?
|
Protein Binding | 2 | 2004 | 9386 | 0.010 |
Why?
|
Clone Cells | 1 | 2004 | 1692 | 0.010 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2002 | 599 | 0.010 |
Why?
|
Arginine | 1 | 2004 | 944 | 0.010 |
Why?
|
Serine | 1 | 2004 | 826 | 0.010 |
Why?
|
Lysine | 1 | 2004 | 1007 | 0.010 |
Why?
|
Crystallography, X-Ray | 1 | 2004 | 2011 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2004 | 1791 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2004 | 3129 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2012 | 12026 | 0.010 |
Why?
|
Animals | 4 | 2019 | 168757 | 0.010 |
Why?
|
Mice | 2 | 2019 | 81183 | 0.010 |
Why?
|
Cattle | 1 | 2002 | 3922 | 0.010 |
Why?
|
Prognosis | 1 | 2017 | 29063 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 40561 | 0.010 |
Why?
|
Time Factors | 1 | 2017 | 40075 | 0.010 |
Why?
|
Ligands | 1 | 2002 | 3282 | 0.010 |
Why?
|
Neoplasms | 1 | 2003 | 21683 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2002 | 3616 | 0.010 |
Why?
|
Binding Sites | 1 | 2003 | 6114 | 0.010 |
Why?
|
Models, Molecular | 1 | 2003 | 5456 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2004 | 13815 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2004 | 9734 | 0.010 |
Why?
|
Cell Line | 1 | 2004 | 15997 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2003 | 7913 | 0.000 |
Why?
|
Cell Line, Tumor | 1 | 2004 | 16689 | 0.000 |
Why?
|
United States | 1 | 2014 | 69872 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 2004 | 21827 | 0.000 |
Why?
|
Concepts
(227)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(52)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_